Beijing Foyou Pharma (601089.SH): Benidipine Hydrochloride Tablets Obtained Drug Registration Certificate.
Fuyuan Pharmaceutical (601089.SH) announced that recently the company received a notice from the National Medical Products Administration (NMPA)...
Beijing Foyou Pharma (601089.SH) announced that it has recently received the Drug Registration Certificate (Certificate No. 2025S02068) for the production of Benidipine Hydrochloride tablets (4mg) from the National Medical Products Administration.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
